{"id":"W2152124092","doi":"10.1200/jco.2013.48.7934","title":"International Myeloma Working Group Consensus Statement for the Management, Treatment, and Supportive Care of Patients With Myeloma Not Eligible for Standard Autologous Stem-Cell Transplantation","year":2014,"lang":"en","type":"review","venue":"Journal of Clinical Oncology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":384,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Cilag; Onyx Pharmaceuticals; National University Health System; Nagoya City University; Gil Medical Center, Gachon University; Genentech; Sahlgrenska Universitetssjukhuset; Università degli Studi di Pavia; Keio University; Cedars-Sinai Medical Center; Weill Cornell Medical College; Abbott Laboratories; Queen Mary University of London; University of Pittsburgh; Ankara Universitesi; University of Arkansas for Medical Sciences; Array BioPharma; Tel Aviv University; Gachon University; York University; Northwestern University; Emory University; American Society of Clinical Oncology; Universität Wien; Celgene; Daiichi Sankyo Europe; National Cancer Institute; Gilead Sciences; National and Kapodistrian University of Athens; Karolinska Institutet; Memorial Sloan-Kettering Cancer Center; Bristol-Myers Squibb; Daiichi-Sankyo; Takeda Oncology; Massachusetts General Hospital; Sanofi; Amgen","keywords":"Medicine; Multiple myeloma; Intensive care medicine; Transplantation; Adverse effect; Lenalidomide; Disease; Anemia; Autologous stem-cell transplantation; Concomitant; Internal medicine; Surgery","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00955902,0.001311322,0.002968763,0.004477034,0.000962527,0.001331811,0.003728564,0.003276366,0.002368982],"category_scores_gemma":[0.00899299,0.000463402,0.002120205,0.003713738,0.0007873969,0.001358197,0.001715179,0.003842314,0.001899585],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002653971,"about_ca_system_score_gemma":0.01841889,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.007874009,"about_ca_topic_score_gemma":0.008372619,"domain_scores_codex":[0.9970472,0.0007575096,0.0007697088,0.0001444572,0.001101755,0.0001792275],"domain_scores_gemma":[0.9925989,0.001656161,0.00122906,0.0001365743,0.003853183,0.0005261258],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001220546,0.0001513922,0.001182243,0.02281954,0.0003237461,0.0003021822,0.0001747024,0.0006209216,0.0006735838,0.003568839,0.3350431,0.6350178],"study_design_scores_gemma":[0.0001233736,0.0001125575,0.003184842,0.03595866,0.0007226879,0.001485644,0.0002742691,0.0002526685,0.0004903295,0.003354576,0.95399,0.00005034005],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0005740709,0.9470447,0.002605038,0.03536496,0.006169379,0.0004352368,0.0008761492,0.00008968131,0.006840814],"genre_scores_gemma":[0.003416237,0.9619495,0.01516435,0.01128949,0.002191956,0.0006396699,0.002495634,0.00002955777,0.002823551],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.00955902,"threshold_uncertainty_score":0.05055356,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1340411982215561,"score_gpt":0.4758519201022766,"score_spread":0.3418107218807206,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}